-
Advisory Committe for Immunization
Practices. Human rabies prevention-United States, 1999. MMWR 1999;
48 (Suppl RR-1): 1-21.
-
CDC. Human rabies, 2000. MMWR 2000;
49: 1111-6.
-
Binghan J. Canine rabies ecology in
Southern Africa. Emerg Infect Dis 2005; 11: 1337-41.
-
Hemachudha T, Laothamatas J,
Rupprecht CH. Human rabies: a disease of complex neuropathogenetic
mechanisms and diagnostic challenges. Lancet Neurology 2002; 1:
101-9.
-
Lafon M. Bat rabies the Achilles
heel of a viral killer?. Lancet 2005; 366: 876-7.
-
Plotkin S. Rabies. Clin Infect Dis
2000; 30: 4-12.
-
Rupprech C, Gibbons R. Clinical
practice. Prophylaxis against rabies. N Engl J Med 2004; 351:
2626-35.
-
Rupprech C, Hanlon C, Hemachudha T.
Rabies re-examined. Lancet Infect Dis 2002; 327-43.
-
Sanchez LP, Abellan C, Diaz O. Rabia en España. ¿Qué
ocurre con la rabia en quirópteros?.Bol Epidemiol Semanal 2002; 10:
109-20.
-
Serra-Cobo J, Amengual B, Abellán
C, Bourhy H. European bat Lyssavirus infection in Spanish bat
populations. Emerg Inf Dis 2002; 8: 413-21.
-
Tantawichien T, Tantawichien Th,
Supit C, Khawplod P, Sitprija V. Three-year experience with 4-site
intradermal booster vaccination with rabies vaccine for postexposure
prophylasis. Clin Infect Dis 2001; 33: 2085-7.
-
Warrell M. The challenge to provide
affordable rabies post-exposure treatment. Vaccine 2003; 21: 706-9.
-
WHO. Rabies vaccine. Weekly
Epidemiol Rec 2002; 14: 109-20.
-
WHO. Rabies Vaccine-update. Weekly
Epidemiol Rec 2007; 82: 62-8.
-
Wilde H, Khawplod P, Hemachudha T,
Sitprija V. Postexposure treatment of rabies infection: can it be
done without immunoglobulin?. Clin Infect Dis 2002; 34: 477-80.
